Haemonetics HAE Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $175.44M+34.9% | $168.19M+35.8% | $163.34M+42.2% | $167.68M+42.6% | ||
| $111.72M-3.3% | $112.61M-2.1% | $114.25M+4.3% | $115.21M+11.5% | $115.59M+18.9% | ||
| $33.83M+14.1% | $31.64M+5.0% | $32.05M+10.1% | $31.32M+8.1% | $29.64M+4.6% | ||
| $293.22M+61.4% | $338.84M+162% | $289.04M+238% | $226.54M+66.8% | $181.73M-0.3% | ||
| $32.78M-16.5% | $30.76M+1.5% | $32.96M-9.5% | $37.38M+3.5% | $39.28M+3.0% | ||
| $60.18M— | —— | —— | —— | —— | ||
| -$179.55M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $6.25M-5.6% | $6.25M-27.0% | $4.69M-61.1% | $4.69M-61.7% | ||
| -$180.49M— | —— | —— | —— | —— | ||
| -$64.85M— | —— | —— | —— | —— | ||
| $260.44M+82.8% | $308.08M+211% | $256.08M— | $189.17M— | $142.45M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.